The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intra-individual genomic diversity between circulating tumor cell-free DNA (cfDNA) and tumor tissue testing in metastatic renal cell carcinoma (mRCC).
 
Andrew W. Hahn
No Relationships to Disclose
 
David Michael Gill
No Relationships to Disclose
 
Jessica Streeter
No Relationships to Disclose
 
Erin B. Bailey
No Relationships to Disclose
 
Emma Carroll
No Relationships to Disclose
 
Lubina Aryal
No Relationships to Disclose
 
Julia A. Batten
No Relationships to Disclose
 
Sumati Gupta
Stock and Other Ownership Interests - Salarius Pharmaceuticals (I)
Consulting or Advisory Role - Keryx (I)
Research Funding - Hydrocephalus Clinical Research Network (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Keryx (I)
 
Neeraj Agarwal
Research Funding - amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Benjamin Louis Maughan
No Relationships to Disclose